Announcements Trials

Browse Landscape

Phase

Phase 1/2 7 Phase 2 5 Phase 3 4 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 66 Breast Neoplasms 64 Prostatic Neoplasms 46 Carcinoma, Non-Small-Cell Lung 40 Neoplasm Metastasis 23 Colorectal Neoplasms 21 Multiple Myeloma 20 Pain 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16 Anemia 16 Keratosis, Actinic 15 Lung Neoplasms 14 Cancer Pain 14 Lymphoma, Non-Hodgkin 12 Lymphoma, Follicular 11 Leukemia 11 Leukemia, Lymphocytic, Chronic, B-Cell 10 Carcinoma, Renal Cell 10 Carcinoma, Hepatocellular 9 Carcinoma 9 Neuroendocrine Tumors 8 Melanoma 8 Lymphoma 8 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Uterine Cervical Neoplasms 6 Recurrence 6 Gastrointestinal Stromal Tumors 6 Stomatitis 5 Stomach Neoplasms 5

Interventions

raltitrexed 1 Oxaliplatin 1 Ethiodized Oil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDUSTRY × Colorectal Cancer Metastatic × Clear all

NCT01959061 2017-03-13

TACE

Nanjing Chia-tai Tianqing Pharmaceutical

Phase 4 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡